T-cell non-Hodgkin's lymphoma after radiotherapy and chemotherapy for Hodgkin's disease

Journal Article · Thu Oct 01 04:00:00 EDT 1981 · Cancer (Philadelphia); (United States)

DOI:https://doi.org/10.1002/1097-0142(19811001)48:7<1586::AID-CNCR2820480719>3.0.CO;2-Y· OSTI ID:5706772

Lowenthal, R M; Harlow, R W.H.; Mead, A E; Tuck, D; Challis, D R

A rapidly fatal T-cell lymphoma developed in a 25-year-old man who, over a period of seven years, had been treated with radiotherapy and combination chemotherapy for Hodgkin's disease (HD). Non-Hodgkin's lymphoma (NHL) is increasingly being recognized as a late sequel of therapy for HD, but this is the first case in which NHL of T-cell type has been identified in such circumstances.

• Research Organization: Univ. Of Tasmania, Australia
• OSTI ID: 5706772
• Journal Information: Cancer (Philadelphia); (United States), Journal Name: Cancer (Philadelphia); (United States) Vol. 48:7; ISSN CANCA
• Country of Publication: United States
• Language: English

Related Subjects

550600 -- Medicine
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CHEMOTHERAPY
DATA
DELAYED RADIATION EFFECTS
DIAGNOSIS
DISEASES
EXPERIMENTAL DATA
HODGKINS DISEASE
IMMUNE REACTIONS
INFORMATION
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUMERICAL DATA
PATIENTS
RADIATION EFFECTS
RADIOLOGY
RADIOTHERAPY
THERAPY